| |
|
|
| |
|
|
| |
Natella Y. Rakhmanina, MD, FAAP, AAHIVS
Contact Information
Children's National Medical Center
Center for Translational Science
111 Michigan Avenue, NW
Washington, DC 20010-2970
202-476-5051
nrakhman@childrensnational.org
Education & Training
| Institution & Location |
Degree |
Year(s) |
Field of Study |
| People’s Friendship University, Medical Faculty, Moscow, Russia |
MD |
1981-1988 |
Medicine |
| People’s Friendship University, Medical Faculty, Moscow, Russia |
Residency |
1988-1990 |
Pediatrics |
| People’s Friendship University, Medical Faculty, Moscow, Russia |
Fellowship |
1990-1991 |
Pediatrics |
| Arkansas Children’s Hospital, University of Arkansas for Medical Sciences, Little Rock, AR |
Residency |
1993-1996 |
Pediatrics |
| Children’s Mercy Hospital, Kansas City, MO |
Board |
1996-1997 |
Allergy and Immunology |
Research Interests
Natella Y. Rakhmanina, MD, FAAP, AAHIVS, focuses her overall research interests on clinical application of therapeutic drug monitoring in the field of pediatric and maternal HIV. Dr. Rakhmanina is an associate professor of Pediatrics, clinic director, and attending physician for Special Immunology Services. She provides care to the HIV-infected children and adolescents in the Children’s National Medical Center-based Clinic serving metropolitan Washington, DC, including parts of Virginia and Maryland. Her researcher centers on pharmacogenetics and pharmacokinetics of HIV treatment in children and adolescents, with the goal to optimize and individualize treatment of HIV-infected pediatric patients. Since 2004, Dr. Rakhmanina has received an NIH-sponsored Clinical Research Scholarship (K-12 award) to investigate the role of pharmacogenetics and therapeutic drug monitoring in the treatment of HIV-infected children and adolescents. Dr. Rakhmanina is also investigating genetic differences in drug metabolizing enzymes across diverse African ethnic groups.
She is an associate clinical pharmacologist at the Pediatric Pharmacology Research Unit (PPRU) at Children’s National and co-investigator of the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) in Washington, DC. Since 2003, she has chaired the AIDS Drug Committee of the International Association of the Therapeutic Drug Monitoring and Clinical Toxicology.
Clinical Interests
Click here for more information about the doctor’s clinical practice, including how to make an appointment.
Publications
View a partial list of publications for Natella Y. Rakhmanina, MD, FAAP, AAHIVS through the National Library of Medicine's PubMed online database.
Back to Top
|
|
|
|
|
|
